Desmoid Tumors Market Research Report Information: Diagnosis (Biopsy, Electron Microscopy, Immunohistochemical Analysis), Treatment (Surgery, Radiation, Chemotherapy, Medication, Hormone, Molecular Targeted Therapy), End User – Global Forecast till 2023
KEY PLAYERS FOR DESMOID TUMORS MARKET
Amgen Inc., Novartis AG, Abbott Laboratories, Bayer AG, AbbVie Inc., Beckman Coulter Inc., Stryker Corporation, Debiopharm Group, F. Hoffmann-La Roche Ltd, and others.
It is estimated that Desmoid Tumors Market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4859
REGIONAL ANALYSIS FOR DESMOID TUMORS MARKET
The Americas dominate the Desmoid Tumors Market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), it is found that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention.
Europe holds the second position in the Desmoid Tumors Market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.
Asia Pacific is the fastest growing Desmoid Tumors Market owing to the huge patient pool and developing healthcare technology.
The Middle East & Africa has the lowest market for Desmoid Tumors Market due to lack of technical knowledge and poor medical facilities.
SEGMENTATION FOR DESMOID TUMORS MARKET
The Desmoid Tumors Market is segmented on the basis of diagnosis, treatment, and end-user.
On the basis of diagnosis, market is segmented into biopsy, electron microscopic examination, immunohisto chemical analysis, others
On the basis of treatment, market is classified into surgery, radiation therapy, anti-inflammatory medication, hormone therapy, chemotherapy, novel molecular-targeted therapy, others. Novel molecular-targeted therapy is further segmented into gleevec based therapy, and sorafenib based therapy
On the basis of end-user, market is segmented into hospital, clinics, and others.
MARKET SCENARIO FOR DESMOID TUMORS MARKET
Desmoid Tumors are also known as Desmoid fibromatosis. These benign growths occur very rarely in the general population. Desmoid tumor usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. The term Desmoid was derived from the Greek word Desmos, which means tendonlike. Desmoid tumors appear as well-differentiated, and firm overgrowths of fibrous tissue. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic Desmoid Tumors.
On molecular level, Desmoid Tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological differential diagnosis is difficult.
Get Discount @ https://www.marketresearchfuture.com/check-discount/4859 .
BRIFC FOR TOC FOR DESMOID TUMORS MARKET
CHAPTER 1. Report Prologue
CHAPTER 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
CHAPTER 3. RESEARCH METHODOLOGY
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
CHAPTER 4. MARKET DYNAMICS
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
CHAPTER 5. MARKET FACTOR ANALYSIS
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
LIST OF TABLES
Table 1 Desmoid Tumor Industry Synopsis, 2017 – 2023
Table 2 Desmoid Tumor Market Estimates and Forecast, 2017 – 2023, (USD Million)
Table 3 Desmoid Tumor Market by Region, 2017 – 2023, (USD Million)
Table 4 Desmoid Tumor Market by Diagnosis, 2017 – 2023, (USD Million)
Table 5 Desmoid Tumor Market by Treatment, 2017 – 2023, (USD Million)
Table 6 Desmoid Tumor Market by End Users, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Desmoid Tumor Market
Figure 3 Segmentation Market Dynamics for Desmoid Tumor Market
Figure 4 Global Desmoid Tumor Market Share, By Diagnosis 2016
Figure 5 Global Desmoid Tumor Market Share, By Treatment 2016
Figure 6 Global Desmoid Tumor Market Share, By End Users, 2016
Figure 7 Global Desmoid Tumor Market Share, By Region, 2016
For more Enquire @ https://www.marketresearchfuture.com/enquiry/4859
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –